001     304462
005     20250914022636.0
024 7 _ |a 10.1038/s41416-025-03140-z
|2 doi
024 7 _ |a pmid:40914744
|2 pmid
024 7 _ |a 0007-0920
|2 ISSN
024 7 _ |a 1532-1827
|2 ISSN
024 7 _ |a altmetric:181166759
|2 altmetric
037 _ _ |a DKFZ-2025-01855
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mok, Yejin
|b 0
245 _ _ |a Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.
260 _ _ |a Edinburgh
|c 2025
|b Nature Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1757409463_22247
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Surapaneni, Aditya
|b 1
700 1 _ |a Sang, Yingying
|b 2
700 1 _ |a Coresh, Josef
|b 3
700 1 _ |a Grams, Morgan E
|b 4
700 1 _ |a Matsushita, Kunihiro
|b 5
700 1 _ |a Ballew, Shoshana H
|0 0000-0002-7547-3764
|b 6
700 1 _ |a Alencar de Pinho, Natalia
|b 7
700 1 _ |a Ärnlöv, Johan
|b 8
700 1 _ |a Barreto, Sandhi M
|b 9
700 1 _ |a Bell, Samira
|0 0000-0001-9100-1575
|b 10
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 11
|u dkfz
700 1 _ |a Carrero, Juan-Jesus
|0 0000-0003-4763-2024
|b 12
700 1 _ |a Chinnadurai, Rajkumar
|b 13
700 1 _ |a Ciemins, Elizabeth
|b 14
700 1 _ |a Gansevoort, Ron T
|b 15
700 1 _ |a Jassal, Simerjot K
|b 16
700 1 _ |a Jung, Keum Ji
|0 0000-0003-4993-0666
|b 17
700 1 _ |a Kirchner, H Lester
|b 18
700 1 _ |a Konta, Tsuneo
|b 19
700 1 _ |a Kovesdy, Csaba P
|0 0000-0002-8204-911X
|b 20
700 1 _ |a Luo, Li
|b 21
700 1 _ |a Pandit, Krutika
|b 22
700 1 _ |a Rahman, Mahboob
|b 23
700 1 _ |a Robinson-Cohen, Cassianne
|b 24
700 1 _ |a Sabanayagam, Charumathi
|0 0000-0002-4042-4719
|b 25
700 1 _ |a Schultheiss, Ulla T
|0 0000-0002-7541-5310
|b 26
700 1 _ |a Shlipak, Michael
|b 27
700 1 _ |a Staplin, Natalie
|b 28
700 1 _ |a Tonelli, Marcello
|b 29
700 1 _ |a Wang, Angela Yee-Moon
|b 30
700 1 _ |a Wen, Chi-Pang
|0 0000-0001-7896-2558
|b 31
700 1 _ |a Woodward, Mark
|0 0000-0001-9800-5296
|b 32
700 1 _ |a Lees, Jennifer S
|0 0000-0001-6331-0178
|b 33
700 1 _ |a Consortium, CKD Prognosis
|b 34
|e Collaboration Author
700 1 _ |a Harris, Katie
|b 35
|e Contributor
700 1 _ |a Arima, Hisatomi
|b 36
|e Contributor
700 1 _ |a Chalmers, John
|b 37
|e Contributor
700 1 _ |a Grams, Morgan
|b 38
|e Contributor
700 1 _ |a Akwo, Elvis
|b 39
|e Contributor
700 1 _ |a He, Jing
|b 40
|e Contributor
700 1 _ |a Lloyd, Anita
|b 41
|e Contributor
700 1 _ |a Alencar de Pinho, Natalia
|b 42
|e Contributor
700 1 _ |a Metzger, Marie
|b 43
|e Contributor
700 1 _ |a Stengel, Bénédicte
|b 44
|e Contributor
700 1 _ |a Hamroun, Aghilès
|b 45
|e Contributor
700 1 _ |a Massy, Ziad
|b 46
|e Contributor
700 1 _ |a Rao, Panduranga
|b 47
|e Contributor
700 1 _ |a Sosa, Giselle
|b 48
|e Contributor
700 1 _ |a Shah, Vallabh
|b 49
|e Contributor
700 1 _ |a Hsu, Jesse
|b 50
|e Contributor
700 1 _ |a Vigo, Alvaro
|b 51
|e Contributor
700 1 _ |a Mill, José Geraldo
|b 52
|e Contributor
700 1 _ |a Lotufo, Paulo
|b 53
|e Contributor
700 1 _ |a Canhada, Scheine
|b 54
|e Contributor
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 55
|e Contributor
|u dkfz
700 1 _ |a Stocker, Hannah
|0 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
|b 56
|e Contributor
|u dkfz
700 1 _ |a Rothenbacher, Dietrich
|b 57
|e Contributor
700 1 _ |a Schneider, Markus P
|b 58
|e Contributor
700 1 _ |a Köttgen, Anna
|b 59
|e Contributor
700 1 _ |a Meiselbach, Heike
|b 60
|e Contributor
700 1 _ |a Eckardt, Kai-Uwe
|b 61
|e Contributor
700 1 _ |a Green, Jamie
|b 62
|e Contributor
700 1 _ |a Chang, Alexander R
|b 63
|e Contributor
700 1 _ |a Singh, Gurmukteshwar
|b 64
|e Contributor
700 1 _ |a Lambourg, Emilie
|b 65
|e Contributor
700 1 _ |a Livingstone, Shona
|b 66
|e Contributor
700 1 _ |a Palmer, Colin
|b 67
|e Contributor
700 1 _ |a Pearson, Ewan
|b 68
|e Contributor
700 1 _ |a Jee, Sun Ha
|b 69
|e Contributor
700 1 _ |a Kimm, Heejin
|b 70
|e Contributor
700 1 _ |a Katz, Ronit
|b 71
|e Contributor
700 1 _ |a Flaherty, Carina
|b 72
|e Contributor
700 1 _ |a Mohl, Jeff
|b 73
|e Contributor
700 1 _ |a Kieneker, Lyanne M
|b 74
|e Contributor
700 1 _ |a Bakker, Stephan Jl
|b 75
|e Contributor
700 1 _ |a van der Vegt, Bert
|b 76
|e Contributor
700 1 _ |a de Boer, Rudolf A
|b 77
|e Contributor
700 1 _ |a Bergstrom, Jaclyn
|b 78
|e Contributor
700 1 _ |a Ix, Joachim
|b 79
|e Contributor
700 1 _ |a Sumida, Keiichi
|b 80
|e Contributor
700 1 _ |a Shrestha, Prabin
|b 81
|e Contributor
700 1 _ |a Cheng, Ching-Yu
|b 82
|e Contributor
700 1 _ |a Wong, Tien Yin
|b 83
|e Contributor
700 1 _ |a Thyagarajan, Pavitra
|b 84
|e Contributor
700 1 _ |a Herrington, William
|b 85
|e Contributor
700 1 _ |a Landray, Martin J
|b 86
|e Contributor
700 1 _ |a Baigent, Colin
|b 87
|e Contributor
700 1 _ |a Kalra, Philip
|b 88
|e Contributor
700 1 _ |a Green, Darren
|b 89
|e Contributor
700 1 _ |a Sinha, Smeeta
|b 90
|e Contributor
700 1 _ |a Ritchie, James
|b 91
|e Contributor
700 1 _ |a Tsai, Min-Kung
|b 92
|e Contributor
700 1 _ |a Lees, Jennifer
|b 93
|e Contributor
700 1 _ |a Larsson, Anders
|b 94
|e Contributor
700 1 _ |a Giedraitis, Vilmantas
|b 95
|e Contributor
700 1 _ |a Levey, Andrew S
|b 96
|e Contributor
700 1 _ |a Nitsch, Dorothea
|b 97
|e Contributor
700 1 _ |a Shlipak, Michael G
|b 98
|e Contributor
773 _ _ |a 10.1038/s41416-025-03140-z
|0 PERI:(DE-600)2002452-6
|p nn
|t British journal of cancer
|v nn
|y 2025
|x 0007-0920
909 C O |o oai:inrepo02.dkfz.de:304462
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 55
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 56
|6 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRIT J CANCER : 2022
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BRIT J CANCER : 2022
|d 2024-12-19
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie der Krebsfrüherkennung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21